Prostate Adenocarcinoma
Showing NaN - NaN of 13
Metastatic Prostate Cancer, Prostate Adenocarcinoma Trial in Worldwide (Cabozantinib, Atezolizumab, Abiraterone Acetate)
Recruiting
- Metastatic Prostate Cancer
- Prostate Adenocarcinoma
- Cabozantinib
- +4 more
-
Tucson, Arizona
- +259 more
Oct 19, 2022
Prostate Adenocarcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in United States
Recruiting
- Prostate Adenocarcinoma
- +6 more
- Gonadotrophin Releasing Hormone
- +2 more
-
Gilbert, Arizona
- +86 more
Sep 27, 2022
Prostate Cancer, Prostate Adenocarcinoma Trial in Canada, United States (Radical Prostatectomy, TULSA Procedure)
Recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Radical Prostatectomy
- TULSA Procedure
-
Tarzana, California
- +7 more
Aug 10, 2022
Localized Prostate Carcinoma, Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 Trial in United States (Apalutamide,
Recruiting
- Localized Prostate Carcinoma
- +8 more
- Apalutamide
- Quality-of-Life Assessment
-
Tucson, Arizona
- +4 more
Jun 28, 2022
Prostate Adenocarcinoma, Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma Trial in Canada, Switzerland, United
Active, not recruiting
- Prostate Adenocarcinoma
- +3 more
- Hypofractionated radiation therapy
- +2 more
-
Birmingham, Alabama
- +240 more
Jun 6, 2022
Prostate Adenocarcinoma, Obesity, Morbid Trial in Baltimore (device, behavioral, drug)
Withdrawn
- Prostate Adenocarcinoma
- Obesity, Morbid
- Bead Block 300-500 um
- +2 more
-
Baltimore, MarylandJohns Hopkins School of Medicine - Sidney Kimmel Comprehensive C
Apr 29, 2022
Prostate Adenocarcinoma, Prostate Cancer, High Risk Prostate Cancer Trial in Baltimore, Boston, Seattle (Enzalutamide,
Completed
- Prostate Adenocarcinoma
- +2 more
- Enzalutamide
- +3 more
-
Baltimore, Maryland
- +3 more
Mar 30, 2022
Prostate Cancer, Prostate Adenocarcinoma, Prostate Cancer Recurrent Trial in Canada, United States (18F-DCFPyL, PET/CT Imaging)
Completed
- Prostate Cancer
- +3 more
- 18F-DCFPyL
- PET/CT Imaging
-
Duarte, California
- +13 more
Jun 10, 2021
Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (Laboratory
Completed
- Hormone-Resistant Prostate Cancer
- +3 more
- Laboratory Biomarker Analysis
- +2 more
-
Washington, District of Columbia
- +19 more
Aug 13, 2018
Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Baltimore (Dexamethasone,
Terminated
- Hormone-Resistant Prostate Cancer
- +3 more
- Dexamethasone
- +3 more
-
Baltimore, MarylandJohns Hopkins University/Sidney Kimmel Cancer Center
Jul 11, 2018
Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in United States (drug, other, procedure)
Completed
- Prostate Adenocarcinoma
- +4 more
- Bicalutamide
- +5 more
-
Los Angeles, California
- +14 more
Sep 18, 2017
Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (drug, other,
Terminated
- Hormone-Resistant Prostate Cancer
- +3 more
- Docetaxel
- +4 more
-
Jacksonville, Florida
- +13 more
Aug 21, 2017
Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in United States (Cholecalciferol, Genistein,
Completed
- Prostate Adenocarcinoma
- +3 more
- Cholecalciferol
- +4 more
-
Birmingham, Alabama
- +10 more
Jun 20, 2016